• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE targets Toshiba's Japanese MRI share

Article

Leadership in MRI market share around the globe is neatly divided,with General Electric holding sway in the U.S., Siemens in Europeand Toshiba in Japan. But GE is looking to upset that balancewith a new 1.5-tesla platform to be marketed exclusively in

Leadership in MRI market share around the globe is neatly divided,with General Electric holding sway in the U.S., Siemens in Europeand Toshiba in Japan. But GE is looking to upset that balancewith a new 1.5-tesla platform to be marketed exclusively in Japan.The scanner, dubbed Sierra, is aimed at knocking Toshiba out ofits position as Japan's MRI king of the mountain.

Sierra is intended to go head-to-head with Toshiba's 150A 1.5-teslasystem, according to Paul J. Mirabella, general manager of GE'sMR division.

"The real thrust of the product as it relates to the competitionand the market (in Japan) is the focus on Toshiba, in particularthe Toshiba 150A," Mirabella said.

Sierra was jointly developed by GE and its Yokogawa MedicalSystems subsidiary. The scanner began shipping last month.

YMS already sells GE's flagship 1.5-tesla Signa in Japan. Butif Signa is a thoroughbred, Sierra will be a workhorse. Sierrais designed to compete in the high-field category but at a pricelower than Signa's.

"In order to cover the market fully, YMS thought it necessaryto develop another version of the 1.5-tesla platform," Mirabellasaid. "This gives us the flexibility of covering more priceswithout having to compromise the price on Signa."

GE supplied the magnet for Sierra, which is an active-shieldedmagnet of the same type as that used in the Signa. GE also suppliedthe system's coils as well as the image acquisition and reconstructionalgorithms.

YMS is touting the system's compactness, which allows it tobe sited in the same amount of space as a mid-field scanner, accordingto the company.

GE is leaving open the option that Sierra could follow in thefootsteps of the 0.5-tesla Vectra, which was introduced in Japanin 1990 before it made its way into the U.S. market last year(SCAN 6/3/92).

"There's the possibility (Sierra) might be marketed inmany other places besides Japan," Mirabella said. "I'mnot saying it will be. I'm saying that the possibility exists."

As well as being an effort to crack Toshiba's position in theJapanese market, Sierra is also a response to the maturing ofthe global MRI market, which demands products at a wider rangeof price levels.

"The global market is getting more mature in MR, muchmore segmented," Mirabella said. "It's an environmentwhere covering a couple of price points all by itself is not goingto play. You've got to cover as many price points (as possible)."

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.